Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pingfu Fu

Showing results (251-260 of 268) with videos related to

Pageof 27
Sort By:
Clinical Genitourinary Cancer|January 13, 2026
Non-Immunotherapy Arm Allocations in Phase 3 Genitourinary Cancer Trials with ImmunotherapyAbby L Grier, Albert Jang, Jeffrey Y Zhong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2026
AI-Based Pathology classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET TrialSebastian Medina, Naoto Tokuyama, Vaishnavi Putcha, et al.
Blood Advances|January 3, 2024
A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemiaLeland L Metheny, Ronald Sobecks, Christina Cho, et al.
European Urology Focus|May 4, 2021
Computationally Derived Cribriform Area Index from Prostate Cancer Hematoxylin and Eosin Images Is Associated with Biochemical Recurrence Following Radical Prostatectomy and Is Most Prognostic in Gleason Grade Group 2Patrick Leo, Sacheth Chandramouli, Xavier Farré, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2023
Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast CancerAvia D Wilkerson, Prerana Bangalore Parthasarathy, Nickolas Stabellini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East AfricaWalter O Mwanda, Jackson Orem, Pingfu Fu, et al.
Journal of the National Cancer Institute|December 1, 2021
An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients With HPV-Associated Oropharyngeal CancerGermán Corredor, Paula Toro, Can Koyuncu, et al.
Hematology (Amsterdam, Netherlands)|January 21, 2017
Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab eraAdam G Starr, Paolo F Caimi, PingFu Fu, et al.
Communications Medicine|December 2, 2024
Blood-based tumor mutational burden impacts clinical outcomes of immune checkpoint inhibitor treated breast and prostate cancersReagan M Barnett, Albert Jang, Sree Lanka, et al.
British Journal of Haematology|July 23, 2016
Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab eraAdam G Starr, Paolo F Caimi, PingFu Fu, et al.
Pageof 27

Showing results (251-260 of 268) with videos related to

Sort By:
Pageof 27
Clinical Genitourinary Cancer|January 13, 2026
Non-Immunotherapy Arm Allocations in Phase 3 Genitourinary Cancer Trials with ImmunotherapyAbby L Grier, Albert Jang, Jeffrey Y Zhong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2026
AI-Based Pathology classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET TrialSebastian Medina, Naoto Tokuyama, Vaishnavi Putcha, et al.
Blood Advances|January 3, 2024
A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemiaLeland L Metheny, Ronald Sobecks, Christina Cho, et al.
European Urology Focus|May 4, 2021
Computationally Derived Cribriform Area Index from Prostate Cancer Hematoxylin and Eosin Images Is Associated with Biochemical Recurrence Following Radical Prostatectomy and Is Most Prognostic in Gleason Grade Group 2Patrick Leo, Sacheth Chandramouli, Xavier Farré, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2023
Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast CancerAvia D Wilkerson, Prerana Bangalore Parthasarathy, Nickolas Stabellini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East AfricaWalter O Mwanda, Jackson Orem, Pingfu Fu, et al.
Journal of the National Cancer Institute|December 1, 2021
An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients With HPV-Associated Oropharyngeal CancerGermán Corredor, Paula Toro, Can Koyuncu, et al.
Hematology (Amsterdam, Netherlands)|January 21, 2017
Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab eraAdam G Starr, Paolo F Caimi, PingFu Fu, et al.
Communications Medicine|December 2, 2024
Blood-based tumor mutational burden impacts clinical outcomes of immune checkpoint inhibitor treated breast and prostate cancersReagan M Barnett, Albert Jang, Sree Lanka, et al.
British Journal of Haematology|July 23, 2016
Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab eraAdam G Starr, Paolo F Caimi, PingFu Fu, et al.
Pageof 27